Literature DB >> 11445803

Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome.

H De Leersnyder1, M C De Blois, B Claustrat, S Romana, U Albrecht, J C Von Kleist-Retzow, B Delobel, G Viot, S Lyonnet, M Vekemans, A Munnich.   

Abstract

OBJECTIVE: The objective was to determine the circadian rhythm of melatonin in the Smith-Magenis syndrome (SMS), which causes behavioral problems and sleep disturbance. STUDY
DESIGN: Questionnaires, sleep consultations, and sleep diaries were obtained in 20 children with SMS (9 girls, 11 boys aged 4 to 17 years). Actigraphy, electroencephalography, and the circadian variations of plasma melatonin, cortisol, and growth hormone were recorded in 8 patients. Early sleep onset, early sleep offset, and sleep attack indicated sleep disturbance.
RESULTS: All children with SMS had a phase shift of their circadian rhythm of melatonin. Time at onset of melatonin secretion was 6 AM +/- 2 (control group: 9 P.M. +/- 2). Peak time was 12 PM +/- 1 (control group: 3:30 AM +/- 1:30), and melatonin offset was at 8 PM +/- 1 (control group: 6 AM +/- 1). Behavioral problems correlated with the inverted circadian rhythm of melatonin.
CONCLUSION: Considering that clock genes mediate the generation of circadian rhythms, we suggest that haploinsufficiency for a circadian system gene mapping to chromosome 17p11.2 may cause the inversion of the circadian rhythm of melatonin in SMS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445803     DOI: 10.1067/mpd.2001.115018

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  40 in total

1.  The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex.

Authors:  Qun He; Ping Cheng; Qiyang He; Yi Liu
Journal:  Genes Dev       Date:  2005-06-16       Impact factor: 11.361

Review 2.  Use of actigraphy for assessment in pediatric sleep research.

Authors:  Lisa J Meltzer; Hawley E Montgomery-Downs; Salvatore P Insana; Colleen M Walsh
Journal:  Sleep Med Rev       Date:  2012-03-15       Impact factor: 11.609

3.  Sleep in Neurodevelopmental Disorders.

Authors:  Anna J Esbensen; Amy J Schwichtenberg
Journal:  Int Rev Res Dev Disabil       Date:  2016

4.  Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations.

Authors:  Philip M Boone; Russel J Reiter; Daniel G Glaze; Dun-Xian Tan; James R Lupski; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

Review 5.  Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes.

Authors:  Juanita Neira-Fresneda; Lorraine Potocki
Journal:  J Pediatr Genet       Date:  2015-09-28

Review 6.  The clock shop: coupled circadian oscillators.

Authors:  Daniel Granados-Fuentes; Erik D Herzog
Journal:  Exp Neurol       Date:  2012-10-23       Impact factor: 5.330

7.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

Review 8.  Melatonin and the skeleton.

Authors:  A K Amstrup; T Sikjaer; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

9.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

10.  Mouse models of genomic syndromes as tools for understanding the basis of complex traits: an example with the smith-magenis and the potocki-lupski syndromes.

Authors:  P Carmona-Mora; J Molina; C A Encina; K Walz
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.